previous
use
tlc
assay
detect
quantifi
modif
found
intern
mrna
mani
method
modifi
label
detect
first
nucleotid
cap
order
use
approach
compar
rel
proport
cap
structur
differ
sourc
first
necessari
establish
mobil
tlc
assay
demonstr
polynucleotid
kinas
preferenti
label
either
nucleotid
neither
triphosph
phosphoramidit
commerci
avail
novel
method
synthesi
incorpor
rna
oligonucleotid
develop
order
get
quick
access
requir
phosphoramidit
build
block
solidphas
oligoribonucleotid
synthesi
perform
select
onestep
methyl
commerci
avail
phosphoramidit
due
high
reactiv
sensit
toward
acid
base
aritomo
rel
mild
phase
transfer
catalysi
ptc
method
condit
iodomethan
sodium
hydroxid
tetrabutylammonium
bromid
product
obtain
major
product
yield
isom
form
byproduct
yield
due
differ
rf
valu
product
easili
separ
via
column
chromatographi
purifi
phosphoramidit
use
directli
rna
synthesi
oligoribonucleotid
synthes
use
standard
protocol
solidphas
rna
synthesi
min
coupl
time
per
nucleotid
last
coupl
step
follow
standard
dmtroff
procedur
oligoribonucleotid
remov
solid
support
deprotect
precipit
desalt
maldi
mass
spectrometri
use
confirm
mass
rna
oligonucleotid
produc
radioact
end
label
oligonucleotid
amgggcugcu
digest
releas
pam
mix
combin
radioact
label
unmodifi
nucleotid
monophosph
rel
mobil
well
characteris
mixtur
separ
tlc
use
solvent
system
previous
establish
posit
fig
show
polynucleotid
kinas
preferenti
label
rna
oligonucleotid
mix
differ
ratio
end
label
digest
nucleas
separ
tlc
spot
correspond
pam
quantifi
use
phosphorimag
result
demonstr
nucleotid
label
equal
effici
polynucleotid
kinas
fig
label
first
nucleotid
follow
poli
rna
prepar
variou
mous
organ
digest
tobacco
acid
pyrophosphatas
remov
cap
expos
end
dephosphoryl
alkalin
phosphatas
phenolchloroform
extract
ethanol
precipit
mrna
transcript
radiolabel
end
use
polynucleotid
kinas
presenc
fold
excess
atp
label
rna
digest
monophosphonucleotid
nucleas
prior
tlc
separ
use
method
new
spot
correspond
methyl
nucleotid
appar
label
sampl
cap
remov
fig
spot
correspond
readili
detect
mrna
sampl
test
pam
ratio
brain
liver
appear
preval
fig
label
condit
atp
polynucleotid
kinas
excess
intens
spot
correspond
unmodifi
nucleotid
well
methyl
nucleotid
indic
actual
rel
abund
decap
mrna
sampl
supplementari
figur
onlin
order
assay
modif
first
transcrib
nucleotid
messag
individu
gene
mrna
liver
testi
decap
endlabel
describ
fragment
nt
hybridis
singl
strand
dna
target
correspond
region
select
messag
dna
target
first
crosslink
mm
mm
teeth
cut
hybond
n
membran
hybrid
wash
membran
subject
phosphorimag
fig
individu
teeth
contain
label
mrna
genespecif
fragment
remov
digest
nucleotid
monophosph
use
nucleas
sampl
individu
spot
onto
tlc
plate
develop
describ
fig
four
mrna
chosen
analysi
apolipoprotein
ai
albumin
alb
protamin
poli
bind
protein
cytoplasm
alb
predominantli
liver
express
messag
wherea
show
testi
specif
express
express
highli
organ
may
subject
translat
regul
unlik
present
activ
translat
polyribosom
mous
testicular
alb
label
nucleotid
cap
adjac
posit
includ
g
u
c
well
consist
multipl
altern
transcript
start
site
around
case
appear
major
nucleotid
modif
unlik
mix
mrna
start
materi
present
compar
fig
b
ratio
alb
respect
slightli
lower
compar
seen
liver
mrna
popul
whole
mrna
testi
tissu
almost
exclus
cap
adjac
posit
fig
ratio
four
time
larger
ratio
testi
mrna
popul
whole
contrast
cap
adjac
nucleotid
transcript
predominantli
unmodifi
although
pronounc
appar
sampl
testi
fig
core
promot
pol
ii
transcrib
gene
may
focus
direct
transcript
initi
singl
site
cluster
adjac
site
may
dispers
multipl
start
site
region
case
focus
promot
transcript
start
site
contain
within
around
inr
yyanwyy
princip
start
site
surround
nucleotid
utilis
vari
recent
highthroughput
sequenc
full
length
mrna
suggest
purin
instead
may
better
represent
inr
consensu
howev
core
promot
sever
close
array
transcript
start
site
differ
initi
rate
rather
initi
singl
thu
gene
give
rise
popul
mrna
differ
start
nucleotid
exampl
messag
initi
predominantli
central
inr
well
second
nucleotid
upstream
wherea
strongli
initi
inr
also
use
surround
u
g
c
site
signific
level
supplementari
figur
onlin
fig
convers
adenosin
follow
cap
follow
convers
fig
known
convers
preferenti
target
certain
messag
ratio
messag
one
gene
mere
reflect
gener
methylas
activ
particular
cell
type
enzym
respons
format
partial
appear
cytosol
enzym
distinct
nuclear
enzym
respons
format
intern
posit
within
whilst
evid
methyl
may
increas
translat
consequ
convert
larg
unknown
crystallograph
observ
suggest
first
nucleotid
may
influenc
interact
cap
bind
protein
crystallograph
analysi
complex
dinucleotid
show
g
disord
howev
substrat
interact
ctermin
loop
key
interact
cloop
hydrogen
bond
amino
group
posit
adenosin
amino
group
target
methyl
methylas
thu
methyl
adenosin
might
influenc
flexibl
orient
ctermin
loop
region
abil
synthes
rna
oligonucleotid
contain
welldefin
posit
facilit
futur
structurefunct
analysi
therefor
direct
synthet
method
prepar
desir
phosphoramidit
reagent
singl
step
commerci
avail
start
materi
via
direct
dramat
improv
access
materi
biolog
evalu
n
ndiisopropyl
phosphoramidit
phosphoramidit
prepar
follow
tetrabutylammonium
bromid
mg
aq
naoh
ml
ad
stir
solut
phosphoramidit
link
technolog
mg
iodomethan
mmol
dichloromethan
ml
vigor
stir
min
ether
water
ad
result
layer
separ
aqueou
layer
extract
ether
combin
organ
extract
dri
volatil
remov
vacuo
phosphoramidit
readili
purifi
column
chromatographi
ethermethanol
afford
phosphoramidit
mg
white
foam
mixtur
diastereoisom
phosphoramidit
mg
white
foam
mixtur
diastereoisom
data
phosphoramidit
phosphoramidit
present
supplementari
tabl
onlin
oligoribonucleotid
amgggcugcu
synthes
abi
dnarna
synthes
mass
spectra
record
use
bruker
ultraflex
iii
mass
spectromet
via
malditof
column
synbasetm
cpg
rna
apart
phosphoramidit
standard
rnaphosphoramidit
reagent
synthes
purchas
link
technolog
ltd
solut
wt
ethanol
obtain
fluka
nmethylpyrrolidinon
nmp
acid
hpa
dowextm
purchas
aldrich
illustra
column
obtain
ge
healthcar
europ
gmbh
dichloromethan
acetonitril
freshli
distil
use
synthes
rna
oligonucleotid
synthes
use
standard
scale
protocol
min
coupl
time
nucleotid
addit
step
polymerbound
oligoribonucleotid
transfer
synthesi
column
ml
microfug
tube
suspend
solut
ml
mixtur
heat
min
cool
room
temperatur
watericebath
centrifug
min
g
supernat
separ
cpg
bead
bead
wash
rnase
free
water
ml
supernat
combin
dri
h
nitrogen
stream
freez
dri
oligoribonucleotid
resuspend
anhydr
solut
solut
ml
nmp
ml
heat
h
cool
room
temperatur
quench
naoac
solut
nbuoh
ml
ad
mixtur
thoroughli
mix
cool
h
encourag
precipit
centrifug
min
g
supernat
remov
pellet
wash
etoh
dri
vacuo
min
dri
precipit
dissolv
rnase
free
water
ml
desalt
use
column
follow
standard
protocol
result
solut
freez
dri
night
leav
oligoribonucleotid
white
foampowd
sampl
maldimass
spectrometri
prepar
ionexchang
bead
rigor
clean
dilut
hcl
wash
water
treat
dilut
final
wash
water
gener
diammonium
citrat
dac
mg
dissolv
water
ml
hpa
mg
dissolv
acetonitrilewat
ml
hpa
solut
filter
dac
solut
ad
prepar
matrix
stock
prior
maldim
acquisit
matrix
stock
mix
oligoribonucleotid
sampl
mix
min
matrix
dri
sampl
solut
spot
onto
sampl
well
allow
dri
prior
confirmatori
analysi
maldim
total
rna
prepar
mous
tissu
use
trizol
reagent
invitrogen
poli
rna
purifi
twice
use
oligo
dt
cellulos
fluka
follow
oligo
dt
magnet
bead
invitrogen
sampl
quantifi
assay
poli
puriti
use
agil
bioanalys
region
correspond
first
nucleotid
target
messag
pcr
amplifi
cdna
use
follow
oligonucleotid
gctccggggaggtcacccacacct
caatgggcccagccgttcctgcagc
albforward
ccccactagcctctggcaaaatgaagtg
albrevers
ggctggggttgtcatctttgtgttgcag
gctgggtgtgcgcgagtcaggggctc
cttgtggatcctatgtagcctcttacg
cggcggttagtgctgagagtgcggag
gaagttcacgtacgcgtagcccaagg
prior
amplif
forward
oligonucleotid
phosphoryl
amplif
product
subsequ
digest
lambda
nucleas
new
england
biolab
leav
singl
strand
antisens
dna
strand
ng
ssdna
spot
onto
mm
mm
teeth
cut
hybond
n
membran
amersham
fig
c
uv
crosslink
stratalink
membran
prehybridis
formamid
denhardt
sd
nacl
mm
sodium
phosphat
buffer
ph
mg
sonic
salmon
sperm
dna
ng
poli
rna
digest
unit
tobacco
acid
pyrophosphatas
epicentr
minut
phosphat
expos
cap
adjac
nucleotid
remov
addit
unit
alkalin
phosphatas
fermenta
incub
minut
phenolchloroform
extract
ethanol
precipit
rna
sampl
resuspend
steril
distil
water
end
label
use
unit
polynucleotid
kinas
pnk
fermenta
mbq
atp
minut
pnk
heat
inactiv
min
reaction
made
steril
distil
water
pass
spin
column
biorad
remov
unincorpor
isotop
aliquot
taken
ad
nucleas
buffer
digest
sigma
one
hour
releas
monophosph
digest
analys
tlc
describ
remain
end
label
rna
fragment
length
approxim
nt
addit
final
concentr
mm
final
concentr
mm
follow
incub
one
hour
sodium
acet
ph
ad
rna
precipit
ethanol
pellet
resuspend
prehybridis
buffer
ad
membran
final
volum
ml
hybridis
overnight
membran
wash
carri
ssc
sd
two
final
wash
carri
ssc
sd
omit
hybridis
membran
expos
storag
phosphor
screen
kscreen
kodak
imag
use
biorad
molecular
imag
fx
combin
quantiti
one
softwar
biorad
individu
teeth
contain
target
mrna
end
label
cap
adjac
posit
cut
digest
nucleas
sigma
final
volum
digest
mix
appli
cellulos
coat
tlc
plate
cm
merck
develop
describ
sk
ch
develop
carri
novel
chemic
synthesi
phosphoramidit
sz
jb
rf
develop
cap
label
protocol
zb
rf
wrote
manuscript
provid
materi
use
comment
author
review
manuscript
